{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:22:01Z","timestamp":1790670121129,"version":"4.1.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T00:00:00Z","timestamp":1314057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1038\/nrneph.2011.109","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T10:30:20Z","timestamp":1314095420000},"page":"556-566","source":"Crossref","is-referenced-by-count":253,"title":["Why kidneys fail in autosomal dominant polycystic kidney disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Jared J.","family":"Grantham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanth","family":"Mulamalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine I.","family":"Swenson-Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,23]]},"reference":[{"key":"BFnrneph2011109_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1681\/ASN.2008050456","volume":"20","author":"F Hildebrandt","year":"2009","unstructured":"Hildebrandt, F., Attanasio, M. & Otto, E. Nephronophthisis: disease mechanisms of a ciliopathy. J. Am. Soc. Nephrol. 20, 23\u201335 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris, P. C. & Torres, V. E. Polycystic kidney disease. Annu. Rev. Med. 60, 321\u2013337 (2009).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph2011109_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.1987.121","volume":"31","author":"JJ Grantham","year":"1987","unstructured":"Grantham, J. J., Geiser, J. L. & Evan, A. P. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 31, 1145\u20131152 (1987).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/ki.1980.43","volume":"17","author":"FE Cuppage","year":"1980","unstructured":"Cuppage, F. E., Huseman, R. A., Chapman, A. & Grantham, J. J. Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int. 17, 372\u2013381 (1980).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR5","first-page":"213","volume":"10","author":"FA Carone","year":"1995","unstructured":"Carone, F. A., Bacallao, R. & Kanwar, Y. S. The pathogenesis of polycystic kidney disease. Histol. Histopathol. 10, 213\u2013221 (1995).","journal-title":"Histol. Histopathol."},{"key":"BFnrneph2011109_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1744-9987.2010.00819.x","volume":"14","author":"I Ishikawa","year":"2010","unstructured":"Ishikawa, I. et al. Long-term natural history of acquired cystic disease of the kidney. Ther. Apher. Dial. 14, 409\u2013416 (2010).","journal-title":"Ther. Apher. Dial."},{"key":"BFnrneph2011109_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ki.1991.192","volume":"40","author":"JJ Grantham","year":"1991","unstructured":"Grantham, J. J. Acquired cystic kidney disease. Kidney Int. 40, 143\u2013152 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR8","first-page":"1","volume":"328","author":"OZ Dalgaard","year":"1957","unstructured":"Dalgaard, O. Z. Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med. Scand. Suppl. 328, 1\u2013255 (1957).","journal-title":"Acta Med. Scand. Suppl."},{"key":"BFnrneph2011109_CR9","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham, J. J. Clinical practice. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 359, 1477\u20131485 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ki.1983.51","volume":"23","author":"KA Franz","year":"1983","unstructured":"Franz, K. A. & Reubi, F. C. Rate of functional deterioration in polycystic kidney disease. Kidney Int. 23, 526\u2013529 (1983).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow, P. A. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 329, 332\u2013342 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR12","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow, P. A. et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 41, 1311\u20131319 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR13","first-page":"1323","volume-title":"Renal Pathology: with Clinical and Functional Correlations","author":"LW Welling","year":"1994","unstructured":"Welling, L. W. & Grantham, J. J. in Renal Pathology: with Clinical and Functional Correlations Vol. 2 (eds Tisher, C. C. & Brenner, B. M.) 1323\u20131354 (J. B. Lippencott, Philadelphia, 1994)."},{"key":"BFnrneph2011109_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/ki.1992.413","volume":"42","author":"M Zeier","year":"1992","unstructured":"Zeier, M. et al. Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int. 42, 1259\u20131265 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2215\/CJN.00360110","volume":"5","author":"E Meijer","year":"2010","unstructured":"Meijer, E. et al. Early renal abnormalities in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 1091\u20131098 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ki.1989.38","volume":"35","author":"PA Gabow","year":"1989","unstructured":"Gabow, P. A. et al. The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int. 35, 675\u2013680 (1989).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","volume":"5","author":"AB Chapman","year":"1994","unstructured":"Chapman, A. B., Johnson, A. M., Gabow, P. A. & Schrier, R. W. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 5, 1349\u20131354 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR18","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J. et al. Volume progression in polycystic kidney disease. N. Engl. J. Med. 354, 2122\u20132130 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2008.558","volume":"75","author":"AD Kistler","year":"2009","unstructured":"Kistler, A. D. et al. Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney Int. 75, 235\u2013241 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR20","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1046\/j.1523-1755.2000.00433.x","volume":"58","author":"C Sise","year":"2000","unstructured":"Sise, C. et al. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int. 58, 2492\u20132501 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR21","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.V1181505","volume":"11","author":"BF King","year":"2000","unstructured":"King, B. F., Reed, J. E., Bergstralh, E. J., Sheedy, P. F. 2nd & Torres, V. E. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 11, 1505\u20131511 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2215\/CJN.02251205","volume":"1","author":"L Antiga","year":"2006","unstructured":"Antiga, L. et al. Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report. Clin. J. Am. Soc. Nephrol. 1, 754\u2013760 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR23","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","volume":"5","author":"S Klahr","year":"1995","unstructured":"Klahr, S. et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J. Am. Soc. Nephrol. 5, 2037\u20132047 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1172\/JCI106898","volume":"51","author":"LW Welling","year":"1972","unstructured":"Welling, L. W. & Grantham, J. J. Physical properties of isolated perfused renal tubules and tubular basement membranes. J. Clin. Invest. 51, 1063\u20131075 (1972).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011109_CR25","first-page":"661","volume-title":"Anthology of the Kidney","author":"KM Madsen","year":"1994","unstructured":"Madsen, K. M. & Brenner, B. M. in Anthology of the Kidney Vol. 1 (eds Tisher, C. C. & Brenner, B. M.) 661\u2013698 (J. B. Lippencott, Philadelphia, 1994)."},{"key":"BFnrneph2011109_CR26","first-page":"783","volume-title":"Brenner & Rector's The Kidney","author":"MW Taal","year":"2008","unstructured":"Taal, M. W. & Brenner, B. M. in Brenner & Rector's The Kidney Vol. 1 (ed. Brenner, B. M.) 783\u2013819 (Saunders, Philadelphia, 2008)."},{"key":"BFnrneph2011109_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneph.2009.214","volume":"6","author":"KT Bae","year":"2010","unstructured":"Bae, K. T. & Grantham, J. J. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat. Rev. Nephrol. 6, 96\u2013106 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2011109_CR28","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1177\/002215540305101212","volume":"51","author":"L Muskhelishvili","year":"2003","unstructured":"Muskhelishvili, L., Latendresse, J. R., Kodell, R. L. & Henderson, E. B. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J. Histochem. Cytochem. 51, 1681\u20131688 (2003).","journal-title":"J. Histochem. Cytochem."},{"key":"BFnrneph2011109_CR29","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","volume":"18","author":"H Happ\u00e9","year":"2009","unstructured":"Happ\u00e9, H. et al. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum. Mol. Genet. 18, 2532\u20132542 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2011109_CR30","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ndt\/gfl150","volume":"21","author":"MY Chang","year":"2006","unstructured":"Chang, M. Y. et al. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol. Dial. Transplant. 21, 2078\u20132084 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011109_CR31","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1681\/ASN.V3121841","volume":"3","author":"JJ Grantham","year":"1993","unstructured":"Grantham, J. J. 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J. Am. Soc. Nephrol. 3, 1841\u20131857 (1993).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR32","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1056\/NEJM196910302811804","volume":"281","author":"KD Gardner Jr.","year":"1969","unstructured":"Gardner, K. D. Jr. Composition of fluid in twelve cysts of a polycystic kidney. N. Engl. J. Med. 281, 985\u2013988 (1969).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ki.1980.148","volume":"18","author":"R Huseman","year":"1980","unstructured":"Huseman, R., Grady, A., Welling, D. & Grantham, J. Macropuncture study of polycystic disease in adult human kidneys. Kidney Int. 18, 375\u2013385 (1980).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR34","first-page":"457","volume":"1","author":"RR Verani","year":"1988","unstructured":"Verani, R. R. & Silva, F. G. Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study. Mod. Pathol. 1, 457\u2013463 (1988).","journal-title":"Mod. Pathol."},{"key":"BFnrneph2011109_CR35","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1152\/physrev.1998.78.4.1165","volume":"78","author":"LP Sullivan","year":"1998","unstructured":"Sullivan, L. P., Wallace, D. P. & Grantham, J. J. Epithelial transport in polycystic kidney disease. Physiol. Rev. 78, 1165\u20131191 (1998).","journal-title":"Physiol. Rev."},{"issue":"10","key":"BFnrneph2011109_CR36","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","volume":"1812","author":"Darren P. Wallace","year":"2011","unstructured":"Wallace, D. P. Cyclic AMP-mediated cyst expansion. Biochim. Biophys. Acta doi:10.1016\/j.bbadis.2010.11.005.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"BFnrneph2011109_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/NEJM199507063330104","volume":"333","author":"D Woo","year":"1995","unstructured":"Woo, D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 333, 18\u201325 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR38","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1681\/ASN.2006030251","volume":"17","author":"S Nagao","year":"2006","unstructured":"Nagao, S. et al. Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J. Am. Soc. Nephrol. 17, 2220\u20132227 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2369-8-12","volume":"8","author":"JY Park","year":"2007","unstructured":"Park, J. Y. et al. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. BMC Nephrol. 8, 12 (2007).","journal-title":"BMC Nephrol."},{"key":"BFnrneph2011109_CR40","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1100\/tsw.2007.274","volume":"7","author":"S Ibrahim","year":"2007","unstructured":"Ibrahim, S. Increased apoptosis and proliferative capacity are early events in cyst formation in autosomal-dominant, polycystic kidney disease. ScientificWorldJournal 7, 1757\u20131767 (2007).","journal-title":"ScientificWorldJournal"},{"key":"BFnrneph2011109_CR41","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00467-008-0851-9","volume":"23","author":"B Goilav","year":"2008","unstructured":"Goilav, B., Satlin, L. M. & Wilson, P. D. Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases. Pediatr. Nephrol. 23, 1473\u20131482 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2011109_CR42","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2215\/CJN.05611207","volume":"3","author":"CL Edelstein","year":"2008","unstructured":"Edelstein, C. L. Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1219\u20131226 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"BFnrneph2011109_CR43","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bbadis.2011.01.006","volume":"1812","author":"B\u00e9atrice Goilav","year":"2011","unstructured":"Goilav, B. Apoptosis in polycystic kidney disease. Biochim. Biophys. Acta doi:10.1016\/j.bbadis.2011.01.006.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"BFnrneph2011109_CR44","doi-asserted-by":"publisher","first-page":"F870","DOI":"10.1152\/ajprenal.00153.2003","volume":"285","author":"RB Thomson","year":"2003","unstructured":"Thomson, R. B. et al. Histopathological analysis of renal cystic epithelia in the Pkd2WS25\/\u2013 mouse model of ADPKD. Am. J. Physiol. Renal Physiol. 285, F870\u2013F880 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2011109_CR45","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1073\/pnas.93.19.10206","volume":"93","author":"SR Brill","year":"1996","unstructured":"Brill, S. R. et al. Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. Proc. Natl Acad. Sci. USA 93, 10206\u201310211 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2011109_CR46","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ki.1996.304","volume":"50","author":"CJ Davidow","year":"1996","unstructured":"Davidow, C. J., Maser, R. L., Rome, L. A., Calvet, J. P. & Grantham, J. J. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int. 50, 208\u2013218 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR47","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","volume":"66","author":"FA Belibi","year":"2004","unstructured":"Belibi, F. A. et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 66, 964\u2013973 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","volume":"24","author":"VH Gattone 2nd","year":"1999","unstructured":"Gattone, V. H. 2nd, Maser, R. L., Tian, C., Rosenberg, J. M. & Branden, M. G. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev. Genet. 24, 309\u2013318 (1999).","journal-title":"Dev. Genet."},{"key":"BFnrneph2011109_CR49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","volume":"16","author":"X Wang","year":"2005","unstructured":"Wang, X., Gattone, V. 2nd, Harris, P. C. & Torres, V. E. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J. Am. Soc. Nephrol. 16, 846\u2013851 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1681\/ASN.2007060688","volume":"19","author":"X Wang","year":"2008","unstructured":"Wang, X., Wu, Y., Ward, C. J., Harris, P. C. & Torres, V. E. Vasopressin directly regulates cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 19, 102\u2013108 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0140-6736(86)92557-2","volume":"2","author":"ST Reeders","year":"1986","unstructured":"Reeders, S. T. et al. Prenatal diagnosis of autosomal dominant polycystic kidney disease with a DNA probe. Lancet 2, 6\u20138 (1986).","journal-title":"Lancet"},{"key":"BFnrneph2011109_CR52","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2215\/CJN.03750708","volume":"4","author":"KT Bae","year":"2009","unstructured":"Bae, K. T. et al. MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin. J. Am. Soc. Nephrol. 4, 719\u2013725 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2215\/CJN.03780410","volume":"6","author":"MA Cadnapaphornchai","year":"2011","unstructured":"Cadnapaphornchai, M. A., Masoumi, A., Strain, J. D., McFann, K. & Schrier, R. W. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. Clin. J. Am. Soc. Nephrol. 6, 369\u2013376 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J., Chapman, A. B. & Torres, V. E. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin. J. Am. Soc. Nephrol. 1, 148\u2013157 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR55","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2215\/CJN.00550110","volume":"5","author":"JJ Grantham","year":"2010","unstructured":"Grantham, J. J., Cook, L. T., Wetzel, L. H., Cadnapaphornchai, M. A. & Bae, K. T. Evidence of extraordinary growth in the progressive enlargement of renal cysts. Clin. J. Am. Soc. Nephrol. 5, 889\u2013896 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR56","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1681\/ASN.2006080835","volume":"17","author":"PC Harris","year":"2006","unstructured":"Harris, P. C. et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 17, 3013\u20133019 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ki.1985.127","volume":"28","author":"JJ Grantham","year":"1985","unstructured":"Grantham, J. J. & Levine, E. Acquired cystic disease: replacing one kidney disease with another. Kidney Int. 28, 99\u2013105 (1985).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR58","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","volume":"323","author":"AB Chapman","year":"1990","unstructured":"Chapman, A. B., Johnson, A., Gabow, P. A. & Schrier, R. W. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N. Engl. J. Med. 323, 1091\u20131096 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2215\/CJN.04310709","volume":"5","author":"AB Chapman","year":"2010","unstructured":"Chapman, A. B. et al. The HALT polycystic kidney disease trials: design and implementation. Clin. J. Am. Soc. Nephrol. 5, 102\u2013109 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR60","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s004670050343","volume":"11","author":"T Seeman","year":"1997","unstructured":"Seeman, T. et al. Blood pressure and renal function in autosomal dominant polycystic kidney disease. Pediatr. Nephrol. 11, 592\u2013596 (1997).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2011109_CR61","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","volume":"59","author":"GM Fick-Brosnahan","year":"2001","unstructured":"Fick-Brosnahan, G. M., Tran, Z. V., Johnson, A. M., Strain, J. D. & Gabow, P. A. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 59, 1654\u20131662 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR62","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/ki.1979.191","volume":"16","author":"AP Evan","year":"1979","unstructured":"Evan, A. P., Gardner, K. D. Jr & Bernstein, J. Polypoid and papillary epithelial hyperplasia: a potential cause of ductal obstruction in adult polycystic disease. Kidney Int. 16, 743\u2013750 (1979).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR63","first-page":"67","volume-title":"Renal Pathology with Clinical and Functional Correlations","author":"WL Clapp","year":"1989","unstructured":"Clapp, W. L. & Tisher, C. C. in Renal Pathology with Clinical and Functional Correlations Vol. 1 (eds Tisher, C. C. & Brenner, B. M.) 67\u201389 (J. B. Lippencott, Philadelphia, 1989)."},{"key":"BFnrneph2011109_CR64","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1681\/ASN.V7102142","volume":"7","author":"R Torra","year":"1996","unstructured":"Torra, R. et al. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J. Am. Soc. Nephrol. 7, 2142\u20132151 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer, N. et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353, 103\u2013107 (1999).","journal-title":"Lancet"},{"key":"BFnrneph2011109_CR66","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/ajkd.2000.17619","volume":"36","author":"R Torra","year":"2000","unstructured":"Torra, R. et al. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am. J. Kidney Dis. 36, 728\u2013734 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2011109_CR67","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1681\/ASN.2005060601","volume":"16","author":"JH Brown","year":"2005","unstructured":"Brown, J. H. et al. Missense mutation in sterile \u03b1 motif of novel protein SamCystin is associated with polycystic kidney disease in (cy\/+) rat. J. Am. Soc. Nephrol. 16, 3517\u20133526 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR68","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ki.1996.387","volume":"50","author":"GA Tanner","year":"1996","unstructured":"Tanner, G. A., Gretz, N., Connors, B. A., Evan, A. P. & Steinhausen, M. Role of obstruction in autosomal dominant polycystic kidney disease in rats. Kidney Int. 50, 873\u2013886 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR69","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ki.1989.300","volume":"36","author":"GA Tanner","year":"1989","unstructured":"Tanner, G. A. & Evan, A. P. Glomerular and proximal tubular morphology after single nephron obstruction. Kidney Int. 36, 1050\u20131060 (1989).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000045532","volume":"84","author":"RL Chevalier","year":"2000","unstructured":"Chevalier, R. L. Obstructive nephropathy: lessons from cystic kidney disease. Nephron 84, 6\u201312 (2000).","journal-title":"Nephron"},{"key":"BFnrneph2011109_CR71","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2009.86","volume":"75","author":"RL Chevalier","year":"2009","unstructured":"Chevalier, R. L., Forbes, M. S. & Thornhill, B. A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75, 1145\u20131152 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR72","doi-asserted-by":"crossref","unstructured":"Klahr, S. & Morrissey, J. Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int. Suppl. S105\u2013S112 (2003).","DOI":"10.1046\/j.1523-1755.64.s87.16.x"},{"key":"BFnrneph2011109_CR73","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00467-009-1316-5","volume":"25","author":"RL Chevalier","year":"2010","unstructured":"Chevalier, R. L., Thornhill, B. A., Forbes, M. S. & Kiley, S. C. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr. Nephrol. 25, 687\u2013697 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2011109_CR74","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ki.1992.297","volume":"42","author":"VE Torres","year":"1992","unstructured":"Torres, V. E. et al. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int. 42, 364\u2013373 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR75","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2215\/CJN.00910306","volume":"2","author":"VE Torres","year":"2007","unstructured":"Torres, V. E. et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 2, 112\u2013120 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR76","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1681\/ASN.V134991","volume":"13","author":"RL Maser","year":"2002","unstructured":"Maser, R. L., Vassmer, D., Magenheimer, B. S. & Calvet, J. P. Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease. J. Am. Soc. Nephrol. 13, 991\u2013999 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2215\/CJN.04140510","volume":"6","author":"V Menon","year":"2011","unstructured":"Menon, V. et al. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 7\u201313 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR78","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000424395","volume":"115","author":"VE Torres","year":"1995","unstructured":"Torres, V. E. Polycystic liver disease. Contrib. Nephrol. 115, 44\u201352 (1995).","journal-title":"Contrib. Nephrol."},{"key":"BFnrneph2011109_CR79","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1523-1755.2003.00755.x","volume":"63","author":"S Nagao","year":"2003","unstructured":"Nagao, S. et al. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int. 63, 427\u2013437 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR80","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ki.1996.10","volume":"49","author":"L Schaefer","year":"1996","unstructured":"Schaefer, L. et al. Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat. Kidney Int. 49, 75\u201381 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR81","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/ki.1991.87","volume":"39","author":"KD Gardner Jr","year":"1991","unstructured":"Gardner, K. D. Jr, Burnside, J. S., Elzinga, L. W. & Locksley, R. M. Cytokines in fluids from polycystic kidneys. Kidney Int. 39, 718\u2013724 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR82","doi-asserted-by":"publisher","first-page":"F1463","DOI":"10.1152\/ajprenal.90266.2008","volume":"295","author":"DP Wallace","year":"2008","unstructured":"Wallace, D. P. et al. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through \u03b1V-integrin receptor. Am. J. Physiol. Renal Physiol. 295, F1463\u2013F1471 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2011109_CR83","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","volume":"14","author":"D Zheng","year":"2003","unstructured":"Zheng, D. et al. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 14, 2588\u20132595 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"BFnrneph2011109_CR84","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.ajkd.2010.06.023","volume":"56","author":"Esther Meijer","year":"2010","unstructured":"Meijer, E. et al. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Am. J. Kidney Dis. 56, 883\u2013895.","journal-title":"American Journal of Kidney Diseases"},{"key":"BFnrneph2011109_CR85","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","volume":"60","author":"BD Cowley Jr","year":"2001","unstructured":"Cowley, B. D. Jr, Ricardo, S. D., Nagao, S. & Diamond, J. R. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int. 60, 2087\u20132096 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR86","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1744-9987.2010.00819.x","volume":"14","author":"I Ishikawa","year":"2010","unstructured":"Ishikawa, I. et al. Long-term natural history of acquired cystic disease of the kidney. Ther. Apher. Dial. 14, 409\u2013416 (2010).","journal-title":"Ther. Apher. Dial."},{"key":"BFnrneph2011109_CR87","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2005121298","volume":"17","author":"MB Shannon","year":"2006","unstructured":"Shannon, M. B., Patton, B. L., Harvey, S. J. & Miner, J. H. A hypomorphic mutation in the mouse laminin \u03b15 gene causes polycystic kidney disease. J. Am. Soc. Nephrol. 17, 1913\u20131922 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR88","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1242\/dmm.003194","volume":"3","author":"S Mangos","year":"2010","unstructured":"Mangos, S. et al. The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation. Dis. Model Mech. 3, 354\u2013365 (2010).","journal-title":"Dis. Model Mech."},{"key":"BFnrneph2011109_CR89","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","volume":"93","author":"G Wu","year":"1998","unstructured":"Wu, G. et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93, 177\u2013188 (1998).","journal-title":"Cell"},{"key":"BFnrneph2011109_CR90","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1172\/JCI22850","volume":"115","author":"S Nishio","year":"2005","unstructured":"Nishio, S. et al. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J. Clin. Invest. 115, 910\u2013918 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2011109_CR91","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2353\/ajpath.2006.050342","volume":"168","author":"ST Jiang","year":"2006","unstructured":"Jiang, S. T. et al. Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1. Am. J. Pathol. 168, 205\u2013220 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2011109_CR92","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1128\/MCB.26.4.1538-1548.2006","volume":"26","author":"C Thivierge","year":"2006","unstructured":"Thivierge, C. et al. Overexpression of PKD1 causes polycystic kidney disease. Mol. Cell Biol. 26, 1538\u20131548 (2006).","journal-title":"Mol. Cell Biol."},{"key":"BFnrneph2011109_CR93","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek, K., Menezes, L. F., Garcia-Gonzalez, M. A., Huso, D. L. & Germino, G. G. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13, 1490\u20131495 (2007).","journal-title":"Nat. Med."},{"key":"BFnrneph2011109_CR94","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1074\/jbc.M805890200","volume":"284","author":"EY Park","year":"2009","unstructured":"Park, E. Y. et al. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J. Biol. Chem. 284, 7214\u20137222 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2011109_CR95","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ki.2008.659","volume":"75","author":"KL Raphael","year":"2009","unstructured":"Raphael, K. L. et al. Inactivation of Pkd1 in principal cells causes a more severe cystic kidney disease than in intercalated cells. Kidney Int. 75, 626\u2013633 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","volume":"222","author":"S Hassane","year":"2010","unstructured":"Hassane, S. et al. Elevated TGF\u03b2-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease. J. Pathol. 222, 21\u201331 (2010).","journal-title":"J. Pathol."},{"key":"BFnrneph2011109_CR97","doi-asserted-by":"publisher","first-page":"12174","DOI":"10.1073\/pnas.211191098","volume":"98","author":"C Boulter","year":"2001","unstructured":"Boulter, C. et al. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc. Natl Acad. Sci. USA 98, 12174\u201312179 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2011109_CR98","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/ki.1978.75","volume":"13","author":"L Baert","year":"1978","unstructured":"Baert, L. Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int. 13, 519\u2013525 (1978).","journal-title":"Kidney Int."},{"key":"BFnrneph2011109_CR99","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","volume":"87","author":"F Qian","year":"1996","unstructured":"Qian, F., Watnick, T. J., Onuchic, L. F. & Germino, G. G. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87, 979\u2013987 (1996).","journal-title":"Cell"},{"key":"BFnrneph2011109_CR100","first-page":"617","volume":"11","author":"VH Gattone 2nd","year":"1991","unstructured":"Gattone, V. H. 2nd & Grantham, J. J. Understanding human cystic disease through experimental models. Semin. Nephrol. 11, 617\u2013631 (1991).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph2011109_CR101","first-page":"231","volume":"59","author":"VH Gattone 2nd","year":"1988","unstructured":"Gattone, V. H. 2nd et al. Autosomal recessive polycystic kidney disease in a murine model. A gross and microscopic description. Lab. Invest. 59, 231\u2013238 (1988).","journal-title":"Lab. Invest."},{"key":"BFnrneph2011109_CR102","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","volume":"16","author":"IS Lantinga-van Leeuwen","year":"2007","unstructured":"Lantinga-van Leeuwen, I. S. et al. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum. Mol. Genet. 16, 3188\u20133196 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2011109_CR103","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/jcp.1041520318","volume":"152","author":"CA Rankin","year":"1992","unstructured":"Rankin, C. A., Grantham, J. J. & Calvet, J. P. C-fos expression is hypersensitive to serum-stimulation in cultured cystic kidney cells from the C57BL\/6J-cpk mouse. J. Cell Physiol. 152, 578\u2013586 (1992).","journal-title":"J. Cell Physiol."},{"key":"BFnrneph2011109_CR104","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","volume":"18","author":"A Takakura","year":"2009","unstructured":"Takakura, A. et al. Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum. Mol. Genet. 18, 2523\u20132531 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2011109_CR105","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","volume":"17","author":"V Patel","year":"2008","unstructured":"Patel, V. et al. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 17, 1578\u20131590 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph2011109_CR106","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2010.120","volume":"6","author":"P Boor","year":"2010","unstructured":"Boor, P., Ostendorf, T. & Floege, J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat. Rev. Nephrol. 6, 643\u2013656 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2011109_CR107","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/ASN.2010080793","volume":"21","author":"M Zeisberg","year":"2010","unstructured":"Zeisberg, M. & Neilson, E. G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 21, 1819\u20131834 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2011109_CR108","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/ndt\/gfr069","volume":"26","author":"E Meijer","year":"2011","unstructured":"Meijer, E. et al. Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol. Dial. Transplant. 26, 2445\u20132453 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2011109_CR109","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR110","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR111","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1056\/NEJMc1010845","volume":"364","author":"JJ Grantham","year":"2011","unstructured":"Grantham, J. J., Bennett, W. M. & Perrone, R. D. mTOR inhibitors and autosomal dominant polycystic kidney disease. N. Engl. J. Med. 364, 286\u2013287; author reply 287\u2013289 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR112","first-page":"287","volume":"364","author":"WE Braun","year":"2011","unstructured":"Braun, W. E. mTOR inhibitors and autosomal dominant polycystic kidney disease. N. Engl. J. Med. 364, 287; author reply 287\u2013288 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2011109_CR113","first-page":"287","volume":"364","author":"AS Levey","year":"2011","unstructured":"Levey, A. S. & Stevens, L. A. mTOR inhibitors and autosomal dominant polycystic kidney disease. N. Engl. J. Med. 364, 287; author reply 287\u2013289 (2011).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.109","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2011.109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:35:02Z","timestamp":1684456502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2011.109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,23]]},"references-count":113,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["BFnrneph2011109"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2011.109","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,23]]}}}